Skip to content

PHARM TG

Active Private limited companyfounded 2021active for 5 yearsRue de Velaine 7, 5060 SambrevilleKBO/BCE: BE 0775.535.190

Lifetime

5 annual accounts with figures on one time axis
peak of €229,177 in 2024
€193,310▼ 15.7%
lowest -€2,979 in 2022
-€1,577▼ €42,060
peak of €151,329 in 2024
€149,752▼ 1.0%
€864,995▼ 9.3%
peak of 2 FTE in 2023
2 FTEunchanged
Board1 name since 2021
1 director
Documentsfilings and deeds
08-09-202639 days late
2025abbreviated format
Gross margin from €229,177 to €193,310Loss of €1,577

Key points

from the 2025 annual accounts

Turnover

≈ €910,000 estimated

The accounts state no turnover.

Debts

€864,995 85% of the balance sheet
Financial debts 78%Suppliers 4%Taxes and wages 4%Other 13%

€692,427 of the debts are secured on the company's own assets. In 2022 that was €850,519.

Filings

5 annual accounts 5 late
AprilJune31 JulyOctober20222024

The 2021 accounts came in latest, 75 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 1,548 companies had the same profile as PHARM TG has now. Each dot stands for 4 companies, two years later.

91.3%
were still trading
3.9%
stopped another way
4.3%
went bankrupt
  • Micro
  • 5 to 10 years old
  • solvency 10 to 30%
  • a small loss

Another 0.5% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 1,548 companies, not a prediction for PHARM TG. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • founderdeed of 12-10-2021
  • founderdeed of 12-10-2021
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0775535190
Incorporation Founding capital of €5,000, 100 shares · Founded by and · (statutory director) and (statutory director) appointed · published on 12-10-2021 · Gazette deed
First establishment Rue de Velaine 7, Sambreville
All 12 events

Comparable companies

same main activity, similar in size and age
Company
PHARM TG Sambreville €1.0m €193,310 14.8% 2
JMJ PHARMA Orp-Jauche €0.9m €167,539 13.1% 1.8
IDESPHARMA Koksijde €1.3m €191,450 26.4% 2
PHARMAZINNES Namur €0.9m €231,990 13.9% 1.5
PHARMACIE FERMEUSE-BRISMEE Charleroi €0.9m €220,873 -2.5% 2.5
PHARMACIE DELDICQUE-LENFANT SRL Tournai €0.8m €244,060 25.2% 1.8
Pharmacie de Vellereille Merbes-le-Château €1.1m €282,783 10.5% 2.1

These companies have the same main activity as PHARM TG: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €785,000 and €1.3m, founded between 2019 and 2021.

Official details

Source: KBO
Status
Active since 08-10-2021Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730
Establishment unit
2.323.749.6185060 Sambreville, since 08-10-2021
Financial year end
31 December
Peppol
Reachable since 08-12-2025
Company details

Annual accounts 2025

€1.0m▼ 8.2%
Employeeson 31-12-2025
2=
Filing
Filed on 08-09-2026
Financials

Insights on PHARM TG

PHARM TG files the abbreviated format. That format states no turnover. The gross margin rose from €118,637 in 2021 to €193,310 in 2025.

The balance sheet grew most in 2022 through fixed assets, financed with long-term debt.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about PHARM TG

What is the company number of PHARM TG?
The company number of PHARM TG is 0775.535.190. The VAT number is the same number with BE in front: BE 0775.535.190.
Where is PHARM TG based?
The registered office is at Rue de Velaine 7, 5060 Sambreville.Company details
What does PHARM TG do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of PHARM TG?
PHARM TG is a private limited company (BV).
When was PHARM TG founded?
PHARM TG was founded on 08-10-2021.
Is PHARM TG still active?
Yes, PHARM TG is an active enterprise in the KBO register.
How many employees does PHARM TG have?
PHARM TG had an average of 2 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of PHARM TG?
The turnover in financial year 2025 is about €910,000. This figure is estimated from the gross margin of €193,310 and 43 comparable companies (NACE 477). It probably lies between €590,000 and €1.9m.
Is PHARM TG profitable?
In financial year 2025, PHARM TG made a loss of €1,577.
Where can I find the annual accounts of PHARM TG?
PHARM TG filed 5 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of PHARM TG due?
PHARM TG must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.